UR-3216
UR-3216 is a selective, and orally active platelet surface glycoprotein (GPIIb/IIIa) receptor antagonist. UR-3216 has the potential for cardiovascular diseases research[1].
Product Specifications
CAS Number
[220386-65-2]
UNSPSC
12352005
Target
Integrin
Type
Reference compound
Related Pathways
Cytoskeleton
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ur-3216.html
Solubility
10 mM in DMSO
Smiles
O=C(CN1N=C2C(CN(CC2)C([C@H](CC3=CC=C(C=C3)[N+]([O-])=O)NC(C4=CC=C(C=C4)/C(N)=N/O)=O)=O)=C1)OCC
Molecular Formula
C27H29N7O7
Molecular Weight
563.56
References & Citations
[1]K Baba, et al. UR-3216: a manageable oral GPIIb/IIIa antagonist. Cardiovasc Drug Rev. 2001 Spring;19 (1) :25-40.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1092138-01 0.02 mg (E-Coli)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yorQ (yorQ)
Ask
View Details 
MBS1092138-02 0.1 mg (E-Coli)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yorQ (yorQ)
Ask
View Details 
MBS1092138-03 0.02 mg (Yeast)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yorQ (yorQ)
Ask
View Details MBS1092138-04 0.1 mg (Yeast)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yorQ (yorQ)
Ask
View Details 
MBS1092138-05 0.02 mg (Baculovirus)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yorQ (yorQ)
Ask
View Details MBS1092138-06 1 mg (E-Coli)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yorQ (yorQ)
Ask
View Details